产品封面图
文献支持

NVP-HSP990

收藏
  • ¥149 - 4410
  • AmBeed已认证
  • A506817
  • 2026年05月07日
    avatar
    品牌商
    1钻石会员
  • 企业认证

  • 万千商家帮你免费找货

    0 人在求购买到急需产品
    • 详细信息
    • 文献和实验
    • 技术资料
    • 英文名

      (R)-2-Amino-7-(4-fluoro-2-(6-methoxypyridin-2-yl)phenyl)-4-methyl-7,8-dihydropyrido[4,3-d]pyrimidin-5(6H)-one

    • 供应商

      上海安毕达生物科技有限公司

    • CAS号

      934343-74-5

    • 规格

      50μL/1mL/1mg/5mg/10mg/25mg/50mg/100mg

    规格:50μL产品价格:¥149.0
    规格:1mL产品价格:¥809.0
    规格:1mg产品价格:¥161.0
    规格:5mg产品价格:¥472.0
    规格:10mg产品价格:¥787.0
    规格:25mg产品价格:¥1575.0
    规格:50mg产品价格:¥2646.0
    规格:100mg产品价格:¥4410.0
    NVP-HSP990 is a potent and selective HSP90 inhibitor for HSP90α/β with IC50 of 0.6 nM/0.8 nM.

    HSP90 (heat shock protein 90) is a cellular ubiquitous molecular chaperone responsible for promoting the conformational mutation and stabilization of several client oncoproteins, including Met, B-Raf, p53, Akt, and Kit, function of which is required by tumor cells to maintain appropriate client protein expression necessary for proliferation and survival. HSP990 is a potent HSP90 inhibitor with IC50 value of 0.6nM and 0.8nM for Hsp90α and Hsp90β (AlphaScreen competition binding assays), respectively, as well as shows inhibition against GRP94, an HSP90-like protein with IC50 value of 8.5nM. Treatment with HSP990 at concentration of 250nM over 30min could dissociate the complex of HSP90-p23, thus leading to the downregulation of the client protein c-Met and induction of HSP70, the biomarker for HSP90 inhibition, in c-Met amplified GTL-16 gastric tumor cells. In a study of a panel of cell lines and primary patient samples from a variety of tumor types, HSP990 showed anti-proliferation against most of the cells evaluated irrespective of cancer types or genetics, with GI50 values ranging in 4–40nM. In vivo study showed that HSP990 exhibited drug-like pharmaceutical and pharmacologic properties with high oral bioavailability, shown as sustained downregulation of c-Met and upregulation of Hsp70 induced by a single oral administration of 15 mg/kg HSP990. Oral administration of led to significant tumor growth inhibition in the BT-474 breast cancer model at dose of 5mg/kg or 10mg/kg HSP990 per week for 3 weeks, and in the MV4;11 AML model at dose of 5mg/kg twice a week or 10mg/kg once a week for 18 days1.

    溶解方案(细胞实验)

    DMSO 中的溶解度 : ≥ 33 mg/mL (86.98 mM; 吸湿的 DMSO 对产品的溶解度有显著影响,请使用新开封的 DMSO)|* "≥" means soluble, but saturation unknown.

    溶解方案(动物实验)

    "方案 一": "请依序添加每种溶剂:10% DMSO 40% PEG300 5% Tween-80 45% SalineSolubility: ≥ 2.08 mg/mL (5.48 mM); 澄清溶液 此方案可获得 ≥ 2.08 mg/mL(饱和度未知)的澄清溶液。以 1 mL 工作液为例,取 100 μL 20.8 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中,混合均匀;再向上述体系中加入 50 μL Tween-80,混合均匀;然后再继续加入 450 μL 生理盐水 定容至 1 mL。生理盐水的配制:将 0.9 g 氯化钠,溶解于 ddH₂O 并定容至 100 mL,可以得到澄清透明的生理盐水溶液。"

    "方案 二": "请依序添加每种溶剂:10% DMSO 90% Corn OilSolubility: ≥ 2.08 mg/mL (5.48 mM); 澄清溶液 此方案可获得 ≥ 2.08 mg/mL(饱和度未知)的澄清溶液,此方案实验周期在半个月以上的动物实验酌情使用。以 1 mL 工作液为例,取 100 μL 20.8 mg/mL 的澄清 DMSO 储备液加到 900 μL玉米油中,混合均匀。"

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献
    Menezes DL, Taverna P, et al. The novel oral Hsp90 inhibitor NVP-HSP990 exhibits potent and broad-spectrum antitumor activities in vitro and in vivo. Mol Cancer Ther. 2012 Mar;11(3):730-9.
    相关实验
    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥1100
    广州威佳科技有限公司
    2024年04月08日询价
    询价
    谱析(上海)生物科技有限公司
    2025年07月06日询价
    ¥750
    MedChemExpress LLC
    2025年07月12日询价
    ¥266
    TargetMol中国
    2025年07月14日询价
    ¥725
    上海优宁维生物科技股份有限公司
    2025年08月28日询价
    文献支持
    NVP-HSP990
    ¥149 - 4410